Cancer and Leukemia Group B Pathology Committee Guidelines for Tissue Microarray Construction Representing Multicenter Prospective Clinical Trial Tissues

Practice-changing evidence requires confirmation, preferably in multi-institutional clinical trials. The collection of tissue within such trials has enabled biomarker studies and evaluation of companion diagnostic tests. Tissue microarrays (TMAs) have become a standard approach in many cooperative o...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Rimm, David L., Nielsen, Torsten O., Jewell, Scott D., Rohrer, Daniel C., Broadwater, Gloria, Waldman, Frederic, Mitchell, Kisha A., Singh, Baljit, Tsongalis, Gregory J., Frankel, Wendy L., Magliocco, Anthony M., Lara, Jonathan F., Hsi, Eric D., Bleiweiss, Ira J., Badve, Sunil S., Chen, Beiyun, Ravdin, Peter M., Schilsky, Richard L., Thor, Ann, Berry, Donald A.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2011
Onderwerpen:
Special Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3107745/
https://ncbi.nlm.nih.gov/pubmed/21519016
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.33.2023
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items